Skip to main content
. 2020 Jun 30;8(6):2325967120930296. doi: 10.1177/2325967120930296

Table A2.

Consensus Modified Coleman Methodology Score (MCMS) of Evidence Quality by Study

Blood Flow Restriction Supplement Tourniquet Nerve Block
Takarada31 (2000) Iverson15 (2016) Ohta26 (2003) Tyler33 (2004) Laboute19 (2013) Barker6 (2009) Kokki17 (2000) Appell2 (1993) Nicholas25 (2001) Faggal11 (2015) Arciero3 (1996) Abdallah1 (2016) Magnussen24 (2017) Okoroha27 (2018) Runner30 (2018)
MCMS part A
Study size—No. of patients 0 0 4 4 4 0 0 0 4 4 4 7 0 4 7
Mean follow-up 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Percentage of patients with follow-up 5 5 5 3 5 5 5 0 5 5 5 5 5 5 0
No. of interventions per group 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10
Type of study 15 15 15 15 15 15 15 10 15 15 15 15 15 15 15
Diagnostic certainty 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Description of surgical technique 3 3 3 5 3 3 3 3 5 3 5 3 3 3 3
Description of postoperative rehabilitation 0 5 5 3 5 5 0 0 0 5 5 0 0 5 0
MCMS Part B
1. Outcome criteria
 Outcome measures clearly defined 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
 Timing of outcome assessment clear 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
 Use of outcome criteria with reported good reliability 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
 Use of outcome with good sensitivity 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2. Procedure for reporting outcomes
 Patients recruited 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5
 Independent investigator 0 2 0 0 2 0 2 0 2 2 2 2 2 2 0
 Written assessment 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3
 Patient-centered data collected 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3
3. Description of patient selection process
 Selection criteria reported and unbiased 0 5 5 5 5 5 5 5 5 5 5 5 5 5 5
 Recruitment rate reported and ≥80% 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
 Eligible patients not included in the study satisfactorily accounted for 0 0 5 5 0 0 0 0 5 0 5 5 5 5 0
Total MCMS a 48 60 67 65 64 58 55 43 66 64 71 67 60 69 55

aMedian score, 64; range, 43-71.